CalciMedica
Daniel Geffken is the Founder and Managing Director of Danforth Advisors, a company that partners with life science companies to provide specialized services in finance, accounting, and operations. Currently, Daniel holds positions such as Interim Chief Financial Officer at Eloxx Pharmaceuticals and CalciMedica, Chief Financial Officer at Locust Walk Acquisition Corp, and Senior Financial Advisor at various other companies in the life science industry. Daniel holds an MBA from Harvard Business School and a B.S. in Economics from The Wharton School.
This person is not in any offices
CalciMedica
CalciMedica is a privately held, clinical-stage biotechnology company with a platform focused on CRAC channel drug discovery and development for the treatment of acute and severe inflammatory diseases.